NASHVILLE, Tenn., April 27, 2021 /PRNewswire/ -- Cryoport,
Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader
in temperature-controlled supply chain solutions for the life
sciences industry, today announced that the Company will report
financial results for the first quarter ended March 31, 2021 on Tuesday,
May 4, 2021 after U.S. markets close.
In addition to the earnings release, a document titled "Cryoport
First Quarter 2021 in Review", providing a review of Cryoport's
recent financial and operational performance and a general business
update, will be issued at 4:05 pm EDT on
Tuesday, May 4, 2021. The document is designed to be read by
investors before the questions and answers conference call and will
be accessible at
http://ir.cryoport.com/events-and-presentations.
Cryoport management will host a conference call at 5:00 pm EDT on May 4,
2021. The conference call will be in the format of a
questions and answers session and will address any queries
investors have regarding the Company's reported results.
Conference Call Information
Date:
|
May 4,
2021
|
Time:
|
5:00 p.m.
EDT
|
Dial-in
numbers:
|
1-855-327-6837
(U.S.), 1-631-891-4304 (International)
|
Confirmation
code:
|
Request the "Cryoport
Call"
|
Live
webcast:
|
'Investor Relations'
section at www.cryoport.com or at this link. Please allow
10 minutes prior to the call to visit this site to download and
install any
necessary audio software.
|
Questions and answers will be recorded and available
approximately three hours after completion of the live event on the
Investor Relations section of the Company's website at
www.cryoport.com for a limited time. To access the replay of the
questions and answers, please follow this link. A dial-in replay of
the call will also be available to those interested, until
May 11, 2021. To access the replay,
dial +1 844-512-2921 (United
States) or +1 412-317-6671 (International) and enter replay
pin number: 10014267.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is redefining
temperature-controlled supply chain support for the life sciences
industry by continually broadening its platform of solutions and
services, serving the Biopharma, Reproductive Medicine, and Animal
Health markets. Through its family of companies, Cryoport Systems,
MVE Biological Solutions, CRYOPDP and CRYOGENE, Cryoport provides
strategic solutions that support the growing needs of these
markets.
Forward-Looking Statements
Statements in this press release which are not purely
historical, including statements regarding the Company's
intentions, hopes, beliefs, expectations, representations,
projections, plans or predictions of the future, are
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include, but are not limited to, those related to the
Company's industry, business, plans, strategy, acquisitions,
including CRYOPDP and MVE Biological Solutions, financial results
and financial condition. It is important to note that the
Company's actual results could differ materially from those in any
such forward-looking statements. Factors that could cause actual
results to differ materially include, but are not limited to, risks
and uncertainties associated with the effect of changing economic
conditions, trends in the products markets, variations in the
Company's cash flow, market acceptance risks, and technical
development risks. The Company's business could be affected by a
number of other factors, including the risk factors discussed in
the Company's Securities and Exchange Commission ("SEC") reports
including, but not limited to, the Company's Annual Report on Form
10-K for the three and twelve months ended December 31, 2020 and any subsequent filings with
the SEC. The forward-looking statements contained in this press
release speak only as of the date hereof and the Company cautions
investors not to place undue reliance on these forward-looking
statements. Except as required by law, the Company disclaims any
obligation, and does not undertake to update or revise any
forward-looking statements in this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-to-report-first-quarter-2021-financial-results-on-may-4-2021-301277913.html
SOURCE Cryoport, Inc.